ViVitro Labs at Innovation Summit Dublin 2025

 

Jérémie Decressac, ViVitro Labs Business Development Manager, Europe, Middle East, Africa & Asia, will be at Innovation Summit Dublin 2025 April 29-May 1, 2025 in The Shelbourne Hotel Dublin to discuss your cardiovascular device testing needs and the most cost-effective path forward. 

Arrange a time to meet with Jérémie using the attendee partnering app. Or you can send Jérémie an email directly with a preferred time to talk before or after the summit.

Learn how our testing services, ViVitro Heart Valve Accelerated Wear Testing System with DCT™ (Dual Control Technology) and the ViVitro SuperPump Pulsatile Pump accelerate cardiovascular device development with scalable and modular test systems solutions while increasing patient safety at the pre-clinical level with validated test methods. 

Innovation Summit Dublin 2025 will bring together more than 500 leading experts, innovators, and key decision-makers to discuss the critical challenges facing the ever-evolving global medtech community. Innovation Summit conference series are organized as business partnering and networking events where innovative pre-screened emerging medical companies each make a ten minute presentation on their business focus and specific partnering needs.

These presentations are then followed by meetings with interested parties in private breakout rooms. Also included are panel presentations from clinical, investment or other respected opinion leaders that offer added benefit to the conference and further networking opportunity.

---

 

Cardiovascular Device Testing Services

ViVitro Labs offers cardiovascular device testing services as either ISO 17025:2017 accredited or non accredited to help device manufacturers meet the highest standards in the industry in support of regulatory submissions.

 

 

 

 

---

ViVitro Heart Valve Prosthesis AWT System

With Dual Control Technology (DCT)™ for constant leaflet closing velocities during the entire AWT cycling period

ViVitro’s AWT System with DCT™ and pure standalone architecture uses two separate position feedback sensors and algorithms to maintain constant leaflet closing velocities across the entire AWT cycling period. Piston displacement and bypass valve are controlled independently to meet differential pressure requirements while preserving initial leaflet closing velocities.

• Patent pending Dual Control Technology to maintain constant leaflet closing velocities during Accelerated Wear Testing (AWT) and Dynamic Failure Mode (DFM)
• Maximum versatility with pre-wired controller unit and data acquisition system for easy PnP upgrade of up to 6 test modules
• True standalone architecture with independent test modules to avoid disruptions to adjacent on-going test
• Transparent test chambers with inflow, outflow, and lateral visibility for optimum test samples visualization during testing
• Patent pending flow loop system to operate system under low hydrostatic pressure conditions and avoid the need for an external pressure source

---

 

ViVitro SuperPump pulsatile pump

 

The ViVitro SuperPump pulsatile pump can be used to create mock physiological circulatory loops or circulatory flow loops systems for in-vitro testing of cardiovascular medical devices and research applications. From studying cardiovascular pathologies to improve patient treatments to assessing the performance of medical devices under accurate physiological flow conditions, the ViVitro Labs SuperPump pulsatile flow pump and its accessories is the system of choice for building customized circulatory flow loops systems.

The SuperPump is the state-of-the-art engine of any mock circulatory loop or cardiac flow loop systems.   It is designed to generate a pulsating output and can be used to replicate the volumetric displacement, the displacement waveform shape, and the beat rate of the heart. Along with all its accessories, ViVitro offers a modular and a scalable engineering solution to build simple and complex mock circulatory loops or circulatory flow loops to fit medical device development and academic research needs.  The SuperPump is the most widely used pulsatile flow pump in mock circulatory loop or circulatory flow loop systems.

The ViVitro SuperPump pulsatile pump is a digitally controlled hydraulic piston that creates physiological cardiac flows that are unsurpassed in reliability, functionality, and versatility, the AR Series digital technology provides maximum control with precision accuracy. The ViVitro pulsatile flow pump can be combined with ViVitro specific accessories and parts or with independently built components to create scalable systems and generate reliable physiological pulsatile flow conditions in cardiac, peripheral and neurovascular applications.

The SuperPump is the most widely used pulsatile flow pump in the industry for creating mock circulatory flow loop systems. It is used in numerous studies throughout the world.   Visit our Citation Database for the current list of applications and articles.

The SuperPump pulsatile pump provides maximum operator control with precision accuracy. The pump can be controlled by preconfigured waveforms or by customizable ViViTest software input.

 

---

ViVitro Pulse Duplicator system

 

The ViVitro Pulse Duplicator system is the world’s most widely cited and most used in-vitro cardiovascular hydrodynamic testing system. Its unique chamber design can accommodate two prosthetic valves in more anatomically relevant configurations, can be easily adapted to fit the needs of cardiovascular research and innovative device development.

The ViVitro Pulse Duplicator modular design can simulate heart function in left or right flow conditions by generating pulsatile flow through prosthetic heart valves placed in the Model Heart.

Powered by the ViVitro SuperPump pulsatile pump, it is composed of the ViVitro Model Heart (Left or Right), SuperPump pulsatile pump, Flow Measuring System and ViViTest data acquisition system. The components work together to assess the performance of prosthetic heart valves under simulated cardiac conditions. The ViVitro Pulse Duplicator System is used by the US Food and Drug Administration and is recognized and used by regulatory bodies worldwide including TÜV, BSI and Chinese CFDA.

The Pulse Duplicator System assesses the performance of cardiovascular devices and prosthetic heart valves under simulated cardiac conditions. It simulates physiological or other complex flow variations while allowing the user to vary the peripheral resistance and compliance of the system. Pressure ports and flow measuring locations allow for data to be collected from aortic or mitral sites. Transparent viewpoints allow multiple viewing angles of the valve including inflow and outflow.

Combined with the ViViTest software control system, it quickly, easily and reliably collects and analyzes physiological flow and pressure data. The ViViTest software also allows the user to easily modify and customize waveforms.

View ViVitro Pulse Duplicator web page.

The ViVitro Pulse Duplicator System is cited in numerous research studies throughout the world. Visit our Citation Database for the current list of applications and articles.